Silver Nitrate
ApprovedSmall molecule
Silver Nitrate is one of 86 small molecule programs targeting Emphysema. It is currently in Approved.
5
Indications
14
Total Trials
2
Active Trials
85
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
54 competitors in Pleural Effusion
#DrugCompanyPhaseTrials
1Silver Nitrate
MMansoura University Hospital
Approved
Avastin
BBio-Thera Solutions
Phase 3
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3
Opdivo
Bristol-Myers SquibbPhase 2
Sclerosol
SSciarra
Approved
Gemzar
Johnson & JohnsonPhase 2
Aleve
Alnylam PharmaceuticalsPhase 2
MS Contin
Merck & Co.Phase 2
Platinol
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 2
Decadron
AAspen Global Incorporated
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Granulation Tissue3 trials
Granuloma2 trials
Silver Nitrate Versus Topical Steroid For Umbilical Granuloma
Completed·—·Phase 2·NCT06363539·354 enrolled
Pleural effusion2 trials
5 more indications
Epistaxis1 trial
Unspecified1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Silver Nitrate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- MMansoura University Hospital